July 6, 2020
However, when followed by immunomodulatory drugs, researchers found that autologous stem cell transplant can be safely used in this patient population, regardless of CHIP status. Study findings from investigators at the Dana-Farber Cancer Institute indicated that in patients with multiple myeloma treated with autologous stem cell transplant (ASCT), the presence of clonal hematopoiesis of indeterminate...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand